Guest contribution: Article series on the subject of state-of-the-art mycology in dermatology, 11th article by Prof Hans-Jürgen Tietz, Director of the Institute of Fungal Diseases in Berlin, Germany Fungal cultures and their aesthetically pleasing structures will always hold a special place in my heart, but even I must admit that the introduction of PCR into […]
Traditionally, Christmas is the time to reflect on what you have achieved and to turn your attention to those who are less well off. After the very challenging, but also successful last two years, we at EUROIMMUN have decided to support charitable projects for the benefit of disadvantaged children financially at the end of this
It is becoming increasingly clear that not only antibodies against SARS-CoV-2 play a role in building immunity against the coronavirus. T cells, as part of the cellular immune response, also have a major function in the development of immune memory to SARS-CoV-2. Findings from research into immunity to related viruses such as SARS-CoV-1 and MERS-CoV (Middle-East respiratory syndrome coronavirus) have shown that cellular immune responses against these coronaviruses
After a virtually non-existent flu season in 2020/2021 and with the revival of public life and the relaxation of social distancing measures, there is increasing concern that a large flu wave could occur in 2021/2022. It cannot be predicted if or how the missing flu season will affect the coming one, but the Robert Koch
We are delighted to welcome Immunodiagnostic Systems Holding (IDS) as the newest member of the PerkinElmer family. The acquisition of the British diagnostics company was officially closed in July 2021. In future, IDS and EUROIMMUN will closely cooperate in the fields of research and development, production as well as distribution. IDS is a leading company
